Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

US Patent 10556945 · Granted Feb 11, 2020

Estimated economic value: $146,303,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating refractory migraine2024
Conjugated biological molecules, pharmaceutical compositions and methods2024
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating headache comprising administering an antibody to calcitonin gene-relate2023
Treating refractory migraine2021
Treating refractory migraine2021
Conjugated biological molecules, pharmaceutical compositions and methods2021
Treating headache comprising administering an antibody to calcitonin gene-relate2019
Treating headache comprising administering an antibody to calcitonin gene-relate2019
Treating headache comprising administering an antibody to calcitonin gene-relate2019